Brinda Balakrishnan is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 17,523 shares of AUPH, which is worth approximately $162,087. The most recent transaction as insider was on May 21, 2024, when has been sold 520 shares (Common Stock) at a price of $5.74 per share, resulting in proceeds of $2,984. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.5K
0% 3M change
2.88% 12M change
Total Value Held $162,087

Brinda Balakrishnan Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
SELL
Open market or private sale
$2,984 $5.74 p/Share
520 Reduced 2.88%
17,523 Common Stock
May 19 2023
BUY
Grant, award, or other acquisition
-
9,310 Added 34.04%
18,043 Common Stock
May 18 2023
BUY
Exercise of conversion of derivative security
-
8,733 Added 50.0%
8,733 Common Stock
BB

Brinda Balakrishnan

Director
Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH